A Phase One Open Label, Crossover Study in Healthy Adult Subjects to Quantify Lung Deposition and Distribution of 99mTc Radiolabelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Pirfenidone (Primary)
- Indications Acute lung injury; Diabetic nephropathies; Graft-versus-host disease; Heart failure; Idiopathic pulmonary fibrosis; Interstitial lung diseases; Lung transplant rejection; Pulmonary fibrosis
- Focus Pharmacokinetics
- Sponsors Shionogi
- 27 Dec 2020 Status changed from recruiting to completed.
- 24 Nov 2020 New trial record